Oxidative stress is a condition of excessive formation of reactive oxygen species (ROS) and/or deficiency in antioxidant defense systems. Catecholamines and L-DOPA have been speculated to induce oxidative stress by generating excessively ROS via MAO-catalyzed oxidative deamination and via autoxidation. Many lines of evidence have linked oxidative stress and cytotoxicity induced by catecholamines and L-DOPA to various disorders, such as Parkinson's disease, atherosclerosis, etc. SOD activity, XO activity, and the level of lipid peroxidation in rat brains were not changed after treatment with R-($-$)-deprenyl or (±)-M-2-PP. It was demonstrated that R-($-$)-deprenyl, (±)-M-2-PP, and (±)-2-HxMP were unable to suppress the autoxida...
Parkinson's disease affects millions of people worldwide and is characterized by loss of dopaminergi...
L-Deprenyl, a monoamine oxidase (MAO)-B inhibitor, appears to slow down the progression of Parkinson...
3,4-Dihydroxyphenylacetaldehyde (DOPAL) is the focus of the catecholaldehyde hypothesis for the path...
Oxidative stress is a condition of excessive formation of reactive oxygen species (ROS) and/or defi...
Excessive free radical formation or antioxidant enzyme deficiency can result in oxidative stress, a ...
Due to their chemical nature, dopamine and its metabolites are easily oxidized—a process often accom...
Background. The cytotoxic effects of dopamine (DA) on several catecholaminergic cell lines involve D...
Parkinson's disease (PD) is one of the most common neurodegenerative disorders characterized by decr...
""Parkinson's disease (PD) is one of the most common neurodegenerative disorders characterized by de...
grantor: University of TorontoThis study compares the antioxidant versus pro-oxidant poten...
AbstractThe study has demonstrated that dopamine induces membrane depolarization and a loss of phosp...
The preferential loss of dopaminergic neurons in the substantia nigra pars compacta is one of the pa...
L-3,4-Dihydroxyphenylalanin (l-DOPA or levodopa) is currently the most used drug to treat symptoms o...
L-3,4-Dihydroxyphenylalanin (L-DOPA or levodopa) is currently the most used drug to treat symptoms o...
A review. Aberrant oxidative pathways of catecholamine neurotransmitters, i.e. dopamine and norepin...
Parkinson's disease affects millions of people worldwide and is characterized by loss of dopaminergi...
L-Deprenyl, a monoamine oxidase (MAO)-B inhibitor, appears to slow down the progression of Parkinson...
3,4-Dihydroxyphenylacetaldehyde (DOPAL) is the focus of the catecholaldehyde hypothesis for the path...
Oxidative stress is a condition of excessive formation of reactive oxygen species (ROS) and/or defi...
Excessive free radical formation or antioxidant enzyme deficiency can result in oxidative stress, a ...
Due to their chemical nature, dopamine and its metabolites are easily oxidized—a process often accom...
Background. The cytotoxic effects of dopamine (DA) on several catecholaminergic cell lines involve D...
Parkinson's disease (PD) is one of the most common neurodegenerative disorders characterized by decr...
""Parkinson's disease (PD) is one of the most common neurodegenerative disorders characterized by de...
grantor: University of TorontoThis study compares the antioxidant versus pro-oxidant poten...
AbstractThe study has demonstrated that dopamine induces membrane depolarization and a loss of phosp...
The preferential loss of dopaminergic neurons in the substantia nigra pars compacta is one of the pa...
L-3,4-Dihydroxyphenylalanin (l-DOPA or levodopa) is currently the most used drug to treat symptoms o...
L-3,4-Dihydroxyphenylalanin (L-DOPA or levodopa) is currently the most used drug to treat symptoms o...
A review. Aberrant oxidative pathways of catecholamine neurotransmitters, i.e. dopamine and norepin...
Parkinson's disease affects millions of people worldwide and is characterized by loss of dopaminergi...
L-Deprenyl, a monoamine oxidase (MAO)-B inhibitor, appears to slow down the progression of Parkinson...
3,4-Dihydroxyphenylacetaldehyde (DOPAL) is the focus of the catecholaldehyde hypothesis for the path...